Millennium Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Millennium Management’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,595	Closed	-$16K	–	7191
2022 Q4	$16K	Buy	+21,595	New	+$21.4K	﹤0.01%	6099
2021 Q1	–	Sell	-16,248	Closed	-$57K	–	6648
2020 Q4	$57K	Buy	+16,248	New	+$68.6K	﹤0.01%	5078
2020 Q2	–	Sell	-16,521	Closed	-$77K	–	4748
2020 Q1	$77K	Buy	+16,521	New	+$177K	﹤0.01%	3606
2019 Q4	–	Sell	-4,333	Closed	-$45K	–	4756
2019 Q3	$45K	Sell	4,333 -6,704	-61%	-$87.6K	﹤0.01%	4054
2019 Q2	$188K	Buy	11,037 +1,435	+15%	+$38.8K	﹤0.01%	3773
2019 Q1	$324K	Sell	9,602 -27,935	-74%	-$934K	﹤0.01%	3508
2018 Q4	$1.1M	Sell	37,537 -23,079	-38%	-$1.02M	﹤0.01%	2537
2018 Q3	$3.73M	Sell	60,616 -12,769	-17%	-$864K	﹤0.01%	2015
2018 Q2	$5.42M	Buy	73,385 +48,798	+198%	+$3.8M	0.01%	1764
2018 Q1	$1.61M	Buy	24,587 +12,161	+98%	+$918K	﹤0.01%	2439
2017 Q4	$1.04M	Buy	+12,426	New	+$1.22M	﹤0.01%	2678
2017 Q3	–	Sell	-12,784	Closed	-$1.49M	–	3975
2017 Q2	$1.49M	Buy	12,784 +1,283	+11%	+$159K	﹤0.01%	2243
2017 Q1	$1.42M	Buy	11,501 +7,238	+170%	+$948K	﹤0.01%	2199
2016 Q4	$581K	Buy	+4,263	New	+$757K	﹤0.01%	2612
2016 Q2	–	Sell	-27,598	Closed	-$2.58M	–	3708
2016 Q1	$2.58M	Sell	27,598 -15,321	-36%	-$1.67M	0.01%	1645
2015 Q4	$8.7M	Sell	42,919 -56,343	-57%	-$10.1M	0.02%	1002
2015 Q3	$14.4M	Buy	99,262 +46,604	+89%	+$8.55M	0.03%	726
2015 Q2	$11.2M	Buy	52,658 +26,672	+103%	+$6.54M	0.02%	908
2015 Q1	$6.02M	Buy	25,986 +15,270	+142%	+$3.69M	0.01%	1311
2014 Q4	$2.47M	Buy	+10,716	New	+$2.3M	0.01%	1843

Other funds holding BLCM

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Millennium Management's BLCM Position: Q1 2023 in Review

Millennium Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2023, closing a stake of 21,595 shares — an estimated $16K sold.

Millennium Management first reported a position in BLCM in Q4 2014 and held it in 20 quarters. The position peaked at $14.4M in Q3 2015. 25 funds tracked by Wall St. Rank hold BLCM as of Q1 2023.

Millennium Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 21,595 Bellicum Pharmaceuticals, Inc. shares in Q1 2023, an estimated $16K.
Millennium Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 20 quarters.
Millennium Management's Bellicum Pharmaceuticals, Inc. position peaked at $14.4M in Q3 2015.
25 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.